«

»

May 23

The researchers said synbodies have the potential to be not only on proteins of pathogens target.

The researchers said synbodies have the potential to be not only on proteins of pathogens target, but also a useful tool for research into new diagnostic and treatment options.

Stephen Albert Johnston and Chris Diehnelt from the Arizona State University ‘s Biodesign Center for Innovations in Medicine , and colleagues developed a way to make antibodies that make works in reverse: take amino acid sequences and bonded to a synthetic antibodies antibodies or synbody which binds to one or more molecules in the human proteome , the vast repository of protein molecules in humans. In humans.T cell are vital to known man immune defenses against pathogens, but little is known about its early development T – in thymus in the thymus but ultimately comes from hematopoietic stem cells in the bone marrow, of the start all the blood cell types. A stem cell bone marrow being leave to the seed of to the thymic, T cells finally what. The identity of such cell of has long been sought and perhaps help correct disturbances of the T-cell manufacturing, said Avinash Bhandoola, Assistant Professor in of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine.

Do this, but do this, but the thymus regularly imported marrow T-cell progenitors on circulatory system. That cell types of that trips from the bone marrow to the thymus no exclusively downwards, pinned but researchers have HSC themselves. Multipotent progenitor cells cells, or a common lymphoid progenitors cell derived from bone marrow itself, as potential candidates.